Marktgröße und Marktanteil von Direct-to-Consumer-Mikrobiomanalysen bis 2025 – 2031
Direct to Consumer Microbiome Analyzing Market Report Analysis
Direct to Consumer Microbiome Analyzing Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Atlas Biomed Group Limited.
- Viome, Inc.
- 23andMe, Inc
- uBiome
- Carbiotix AB
- BIOMES NGS GmbH
- Quantbiome, Inc.
- TFTAK
Regional Overview

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Mittlerer Osten und Afrika
Market Segmentation

- Darm-Mikrobiom-Testkits
- Gesundheitsproben-Kits
- andere Mikrobiom-Testkits

- Infektionen
- Darmerkrankungen
- Stoffwechselstörungen
- Herz-Kreislauf-Erkrankungen
- andere

- Krankenhäuser
- Kliniken
- Diagnosezentren
- andere

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika